Glucantime
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Meglumine antimonate is the active of Glucantime® used for the treatment of leishmaniasis, a tropical disease caused by parasitic…
Background: The aromatic herb Chenopodium ambrosioides is widely known for its antiparasitic activity. The aim of this study was…
Introduction: Cutaneous leishmaniasis is endemic in Iran. Fasa region (Southern west of Iran) is one of the hot spots. The most…
OBJECTIVE
The treatment of cutaneous leishmaniasis used in Tunisia is Glucantime. The aim of this retrospective study was to…
PURPOSE
The labeling of red blood cells (C) with 99mTc is employed in clinical nuclear medicine for a variety of diagnostic…
Growth inhibition ofLeishmania promastigotes by glucantime was compared in three different media. Glucantime inhibited the growth…
There are evidences that some drugs used for the human diseases can modify the biodistribution of radiopharmaceuticals. The N…
A 70‐year‐old white Brazilian woman from a rural area had a 2‐year history of a painful lesion on her left toe. The lesion…
We treated six patients with mucosal leishmaniasis who failed to respond to glucantime (20 mg/kg/day) with ambisome (2-5 grams…
The therapeutic efficacy of CP-46,665-1, a synthetic lipoidal amine with proven immunomodulatory and anti-tumor properties, in…